← Eichor
Study identifier: NCT06053619 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

Condition: Stroke · Central Nervous System Diseases  ·  Sponsor: University Hospital, Limoges

PhaseNA
Planned participants30
Who can joinAll sexes, 35 Years to 75 Years
Healthy volunteersNo

About this study

The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients. Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.

This description comes directly from the study's public registry record.

Talk to the study team

Maxence COMPAGNAT, MD  ·  555056518  ·  maxence.compagnat@chu-limoges.fr

Charles MORIZIO  ·  charles.morizio@chu-limoges.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de LimogesLimoges, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06053619